A study of nearly 1.8 million adults with diabetes suggests patients with obstructive sleep apnea derive a 20% greater mortality reduction from GLP-1 therapy than those without the sleep disorder.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | GLP-1s linked to elevated rates of hypotensive events | 0 | 0 | 13-06-2026 |
| 2 | Lofta, Accomplish Health to Collaborate on Medical Weight Loss for Sleep Apnea Patients | 0 | 0 | 23-01-2026 |
| 3 | This GLP-1 drug may be best for weight loss | 0 | 0 | 15-06-2026 |
| 4 | Ozempic tied to improved quality of life in type 2 diabetes, CKD | 0 | 0 | 12-06-2026 |
| 5 | New Toolkit Helps Clinicians Integrate Lifestyle Interventions with Obesity Medications | 0 | 0 | 12-05-2026 |
| 6 | Machine Learning Model Predicts CPAP Impact on Cardiovascular Risk in OSA | 0 | 0 | 23-04-2026 |
| 7 | Excessive Napping Linked to Higher Mortality Rates in Older Adults | 0 | 0 | 28-04-2026 |
| 8 | Can wearing a glucose monitor make you healthier? Here’s what happened to students who did | 0 | 0 | 20-06-2026 |
| 9 | Eli Lilly's Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity | 0 | 0 | 31-07-2025 |
